thymidine has been researched along with rosiglitazone in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, T; Haraguchi, K; Hershman, JM; Ohta, K; Onaya, T | 1 |
Andò, S; Aquila, S; Bonofiglio, D; Catalano, S; Gabriele, S; Gentile, M; Giordano, F; Middea, E | 1 |
Amiri, F; Benkirane, K; Diep, QN; El Mabrouk, M; Schiffrin, EL | 1 |
Chou, FP; Lin, TM; Ou, HC; Sheu, WH; Yang, CH | 1 |
Bejjani, DE; Harrill, D; Hileman, C; McComsey, GA; O'riordan, MA; Rizk, N; Ross, AC; Storer, N; Tungsiripat, M | 1 |
1 trial(s) available for thymidine and rosiglitazone
Article | Year |
---|---|
Rosiglitazone improves lipoatrophy in patients receiving thymidine-sparing regimens.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Cholesterol; Double-Blind Method; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; PPAR gamma; Reverse Transcriptase Inhibitors; Rosiglitazone; Thiazolidinediones; Thymidine | 2010 |
4 other study(ies) available for thymidine and rosiglitazone
Article | Year |
---|---|
Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Northern; Carcinoma, Papillary; Cell Division; Chromans; Humans; Male; Mice; Mice, Inbred BALB C; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Thymidine; Thyroid Neoplasms; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2001 |
Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
Topics: Breast Neoplasms; Cell Proliferation; Chromatin Immunoprecipitation; Electrophoretic Mobility Shift Assay; Estradiol; Estrogen Receptor alpha; HeLa Cells; Humans; Ligands; Phosphatidylinositol 3-Kinases; Phosphoric Monoester Hydrolases; Phosphorylation; PPAR gamma; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Signal Transduction; Thiazolidinediones; Thymidine; Transcription, Genetic; Transcriptional Activation; Tumor Suppressor Proteins; Vasodilator Agents | 2005 |
PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Carrier Proteins; Cell Proliferation; Intracellular Signaling Peptides and Proteins; Leucine; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Phosphoproteins; Phosphoric Monoester Hydrolases; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Rosiglitazone; Signal Transduction; Thiazolidinediones; Thymidine | 2006 |
Rosiglitazone inhibits endothelial proliferation and angiogenesis.
Topics: Cell Division; Cell Survival; Cells, Cultured; DNA Replication; Endothelium, Vascular; Humans; Neovascularization, Pathologic; Rosiglitazone; Thiazolidinediones; Thymidine; Umbilical Veins; Vasodilator Agents | 2006 |